🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Systemic Sclerosis With Lung Involvement

Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) NCT06350110Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: CD19- BCMA CAR-T cells Evaluation of Efficacy and Safety of Rituximab and Mycophenolate Mofetil Combination in Patients With Interstitial Lung Disease Related to Systemic Sclerosis NCT06549231Phase 31 site📍 Tours University Hospital, Tours · Tests: Rituximab, Placebo Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases NCT06732674NA1 site📍 Oslo Oslo University Hospital · Tests: A home monitoring strategy with event driven management Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease NCT05785065Phase 23 sites📍 Montreal📍 Montreal📍 Québec Centre hospitalier de l'Université de Montréal (CHUM) · Tests: Mycophenolate Mofetil, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy